Senator Jordon Steele-John, Federal Greens spokesperson on Health, Mental Health and Disability Services, has welcomed the New South Wales Government’s plans for ADHD management.
The State government has announced it will allow up to 1000 GPs to provide ongoing prescriptions for ADHD medication to children and adults, while a smaller number will be trained in diagnosis and to initiate prescriptions of the required medication.
But Senator Steele-John cautioned that while this is a significant step forward, comprehensive national reforms are urgently needed to ensure equitable access to ADHD diagnosis and treatment across Australia, not just in New South Wales.
It’s believed around one in 20 Australians has the condition.
Recommendations from the ADHD inquiry
In 2023, Senator Steele-John initiated a parliamentary inquiry into the availability of ADHD treatment and support services.
The inquiry made 15 recommendations to improve the lives of people with the condition, including:
- Reforming medication prescribing rules
- Implementing a national ADHD framework
- Developing a neurodiversity-affirming public health campaign
- Providing training for healthcare professionals
- Investing in ADHD support and advocacy services
- Conducting further research
While some States have made changes to prescribing rules, the Greens say a nationally consistent approach is essential to ensure all Australians have timely and affordable access to diagnosis and treatment.
“ADHDers across the country face significant barriers to accessing treatment, including high costs and long wait times. The NSW Government’s initiative will help alleviate these challenges for many,” Steele-John said.
“However, the urgency of the situation has not been adequately addressed at the national level. Comprehensive policy changes are needed, and the Australian Government, along with state and territory governments, must act swiftly to implement the inquiry’s recommendations.
“The Federal Government must take a leadership role in coordinating efforts across jurisdictions to ensure consistent and equitable access to ADHD diagnosis and support services nationwide.”